# Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting

> **NCT05615129** · — · COMPLETED · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 350 (actual)

## Conditions studied

- Esophagus Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05615129
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-01
- **Primary completion:** 2022-08-30
- **Final completion:** 2022-10-30
- **Target enrollment:** 350 (ACTUAL)
- **Last updated:** 2022-11-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05615129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05615129, "Sequence and Time-of-day Infusion of immunoCHemotherapy Affect Response in Oesophageal Cancer in the NeOadjuvant Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05615129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*